Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - PTC THERAPEUTICS, INC. | exhibit32112312016.htm |
| EX-31.1 - EXHIBIT 31.1 - PTC THERAPEUTICS, INC. | exhibit31112312016.htm |
| EX-10.19 - EXHIBIT 10.19 - PTC THERAPEUTICS, INC. | exhibit1019rsa.htm |
| EX-31.2 - EXHIBIT 31.2 - PTC THERAPEUTICS, INC. | exhibit31212312016.htm |
| EX-23.1 - EXHIBIT 23.1 - PTC THERAPEUTICS, INC. | exhibit23112312016.htm |
| EX-21.1 - EXHIBIT 21.1 - PTC THERAPEUTICS, INC. | exhibit21112312016.htm |
| 10-K - 10-K - PTC THERAPEUTICS, INC. | ptct1231201610-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of PTC Therapeutics, Inc. (the "Company") for the period ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Shane Kovacs, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 16, 2017 | By: | /s/ SHANE KOVACS | |
Shane Kovacs | |||
Chief Financial Officer | |||
(Principal Financial and Accounting Officer) | |||